A New Revolutionary Nerve-Sensing Technology That Every Investor Should Research

This estimated $100B medical industry is inviting early investors to get in now before a planned Nasdaq listing

Few can imagine traveling with a paper map anymore. Well, that's the equivalent of today's technology when it comes to treating the human nervous system – but this estimated $100B medical industry may be about to get its "GPS" moment. Intended Nasdaq Listing: Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders like never before. And they're inviting early investors to get in now before a planned Nasdaq listing. Potential Industry Disruption: While today's solutions are similar in size to a suitcase, in non-clinical settings Autonomix has achieved thousands of times more sensitive detection and analysis with the same microelectronics found in the Apple Watch – powered by a proprietary 1x2-millimeter microchip. Proven Winners: Their team of scientists has a successful track record. And now, they see a potentially untapped $100B market opportunity like no one else can. See how you can invest in Autonomix before their planned Nasdaq listing. Disclosure: This is a paid advertisement for Autonomix's Regulation A+ Offering. Please read the offering circular at invest.autonomix.com